Elanco Animal Health Investors Notified of Class Action Lawsuit

Have you heard about the recent lawsuit against Elanco Animal Health Incorporated (NYSE: ELAN)? If you’re an investor, there’s important information you need to know. A lawsuit has been filed against Elanco and some of its senior executives for potential violations of federal securities laws. If you’ve invested in Elanco, you can learn more at https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated.

Investors have until December 6, 2024, to take action if they want to be appointed to lead the case. The complaint alleges violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of Elanco Animal Health Incorporated investors. The case is currently in the U.S. District Court of Maryland under the name Barpar v. Elanco Animal Health Incorporated, et al., No. 24-cv-02912.

The core issue of the lawsuit is related to the development pipeline of Elanco. Two critical treatments, Zenrelia for a type of dermatitis in dogs, and Credelio Quattro, a broad-spectrum oral parasiticide, were under FDA review. Elanco had previously mentioned that all technical sections for FDA approval were expected to be completed by the end of June 2024. However, on June 27, 2024, Elanco announced that FDA approval was not forthcoming, and Zenrelia would come with a boxed warning on safety. This news caused Elanco’s stock price to drop over 21% in a single day from $17.97 to $14.27.

This legal action aims to investigate whether Elanco and its executives made false or misleading statements to investors regarding the FDA’s review of its drugs. If you’re an investor who suffered losses, you may have legal options available. BFA Law is there to assist you with a contingency fee basis, meaning there is no upfront cost to you. For more information or to share your details, visit https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated or contact Ross Shikowitz at [email protected] or 212-789-3619.

Bleichmar Fonti & Auld LLP is a well-known law firm with a strong track record in securities class actions and shareholder litigation. The firm has a history of successful cases and is dedicated to seeking justice for investors. To find out more about BFA and its attorneys, you can visit https://www.bfalaw.com. Keep in mind that past results do not guarantee future outcomes. For the original source of this news, head to https://www.newsfilecorp.com/release/230949.